Tech Company Financing Transactions
Fuse Vectors Funding Round
On 2/25/2025, Fuse Vectors raised $5.2 million in Seed funding from HCVC and private investors.
Transaction Overview
Company Name
Announced On
2/25/2025
Transaction Type
Venture Equity
Amount
$5,200,000
Round
Seed
Investors
HCVC (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the development of its technology platform and pipeline of novel gene therapies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Copenhagen, Undisclosed
Denmark
Copenhagen, Undisclosed
Denmark
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Fuse Vectors began with a shared vision among our founders. Driven by their industry experience, Benjamin and Jordan recognized the need for better viral vectors in gene therapy. They took a bold leap to pursue this vision, and along the way, they were joined by Henrik, our executive chair. Starting in a modest lab, our team of experts in molecular biology, bioengineering, and bioprocessing came together with a shared goal of revolutionizing gene therapy. At Fuse Vectors, we are committed to innovation, quality, and excellence. Explore our website to learn more about our groundbreaking work and join us in transforming the future of gene therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benjamin Blaha
Browse more venture capital transactions:
Prev: 2/25/2025: ClearScore venture capital transaction
Next: 2/25/2025: Bitwise Asset Management venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs